nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—CALM1—autonomic nervous system—conduct disorder	0.0925	0.289	CbGeAlD
Bepridil—CACNA1A—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0381	0.0561	CbGpPWpGaD
Bepridil—CACNA1A—brain—conduct disorder	0.0314	0.098	CbGeAlD
Bepridil—PDE1B—brain—conduct disorder	0.0274	0.0855	CbGeAlD
Bepridil—PDE1A—brain—conduct disorder	0.023	0.0717	CbGeAlD
Bepridil—CACNA2D2—brain—conduct disorder	0.0221	0.069	CbGeAlD
Bepridil—KCNQ1—brain—conduct disorder	0.0214	0.0666	CbGeAlD
Bepridil—CACNA1A—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0201	0.0296	CbGpPWpGaD
Bepridil—ATP1A1—Ion channel transport—GABRA2—conduct disorder	0.0199	0.0294	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0197	0.029	CbGpPWpGaD
Bepridil—KCNQ1—Neuronal System—GABRA2—conduct disorder	0.0195	0.0287	CbGpPWpGaD
Bepridil—PDE1A—G alpha (s) signalling events—CGA—conduct disorder	0.0183	0.0269	CbGpPWpGaD
Bepridil—CACNA1H—brain—conduct disorder	0.0179	0.056	CbGeAlD
Bepridil—CACNA2D2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0169	0.0248	CbGpPWpGaD
Bepridil—PDE1B—G alpha (s) signalling events—CGA—conduct disorder	0.0167	0.0246	CbGpPWpGaD
Bepridil—CACNA1A—Neuronal System—GABRA2—conduct disorder	0.0154	0.0227	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0148	0.0218	CbGpPWpGaD
Bepridil—CACNA1D—brain—conduct disorder	0.0148	0.0462	CbGeAlD
Bepridil—CACNA1C—brain—conduct disorder	0.0137	0.0426	CbGeAlD
Bepridil—CACNA2D2—Neuronal System—GABRA2—conduct disorder	0.0129	0.019	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0121	0.0178	CbGpPWpGaD
Bepridil—CALM3—brain—conduct disorder	0.0114	0.0357	CbGeAlD
Bepridil—ATP1A1—brain—conduct disorder	0.0102	0.0318	CbGeAlD
Bepridil—CACNA1A—Transmission across Chemical Synapses—COMT—conduct disorder	0.00968	0.0142	CbGpPWpGaD
Bepridil—CACNA1A—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00961	0.0141	CbGpPWpGaD
Bepridil—KCNQ1—Neuronal System—COMT—conduct disorder	0.00938	0.0138	CbGpPWpGaD
Bepridil—KCNQ1—Neuronal System—MAOA—conduct disorder	0.00932	0.0137	CbGpPWpGaD
Bepridil—CALM1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00918	0.0135	CbGpPWpGaD
Bepridil—CALM2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00918	0.0135	CbGpPWpGaD
Bepridil—CALM2—brain—conduct disorder	0.00899	0.028	CbGeAlD
Bepridil—CALM1—brain—conduct disorder	0.00895	0.0279	CbGeAlD
Bepridil—KCNH2—brain—conduct disorder	0.00814	0.0254	CbGeAlD
Bepridil—CACNA2D2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00811	0.0119	CbGpPWpGaD
Bepridil—CACNA2D2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00805	0.0119	CbGpPWpGaD
Bepridil—CACNA1A—Neuronal System—COMT—conduct disorder	0.00742	0.0109	CbGpPWpGaD
Bepridil—CACNA1A—Neuronal System—MAOA—conduct disorder	0.00736	0.0108	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00729	0.0107	CbGpPWpGaD
Bepridil—KCNH2—Neuronal System—GABRA2—conduct disorder	0.00721	0.0106	CbGpPWpGaD
Bepridil—ATP1A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00694	0.0102	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—MB21D1—conduct disorder	0.00692	0.0102	CbGpPWpGaD
Bepridil—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00678	0.00997	CbGpPWpGaD
Bepridil—KCNQ1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00641	0.00943	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—MB21D1—conduct disorder	0.00633	0.00932	CbGpPWpGaD
Bepridil—CACNA2D2—Neuronal System—COMT—conduct disorder	0.00621	0.00915	CbGpPWpGaD
Bepridil—CACNA2D2—Neuronal System—MAOA—conduct disorder	0.00617	0.00908	CbGpPWpGaD
Bepridil—CALM3—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00597	0.00879	CbGpPWpGaD
Bepridil—CALM2—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00578	0.0085	CbGpPWpGaD
Bepridil—CALM1—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00578	0.0085	CbGpPWpGaD
Bepridil—CALM3—Signaling by VEGF—WASF1—conduct disorder	0.00564	0.00829	CbGpPWpGaD
Bepridil—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00563	0.00829	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00549	0.00808	CbGpPWpGaD
Bepridil—CALM2—Signaling by VEGF—WASF1—conduct disorder	0.00545	0.00802	CbGpPWpGaD
Bepridil—CALM1—Signaling by VEGF—WASF1—conduct disorder	0.00545	0.00802	CbGpPWpGaD
Bepridil—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00545	0.00802	CbGpPWpGaD
Bepridil—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00545	0.00802	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—POLR3A—conduct disorder	0.00508	0.00748	CbGpPWpGaD
Bepridil—CYP2D6—brain—conduct disorder	0.00497	0.0155	CbGeAlD
Bepridil—PDE1B—Innate Immune System—POLR3A—conduct disorder	0.00465	0.00684	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00448	0.00659	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—WASF1—conduct disorder	0.00428	0.00629	CbGpPWpGaD
Bepridil—CALM3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00424	0.00623	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—CGA—conduct disorder	0.00414	0.00609	CbGpPWpGaD
Bepridil—CALM1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0041	0.00603	CbGpPWpGaD
Bepridil—CALM2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0041	0.00603	CbGpPWpGaD
Bepridil—PDE1A—Immune System—MB21D1—conduct disorder	0.00403	0.00593	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—WASF1—conduct disorder	0.00391	0.00576	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—CGA—conduct disorder	0.00375	0.00551	CbGpPWpGaD
Bepridil—PDE1B—Immune System—MB21D1—conduct disorder	0.00369	0.00543	CbGpPWpGaD
Bepridil—ABCB1—brain—conduct disorder	0.00357	0.0111	CbGeAlD
Bepridil—KCNH2—Neuronal System—COMT—conduct disorder	0.00347	0.00511	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—CGA—conduct disorder	0.00347	0.0051	CbGpPWpGaD
Bepridil—KCNH2—Neuronal System—MAOA—conduct disorder	0.00345	0.00507	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—CGA—conduct disorder	0.00343	0.00504	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—CGA—conduct disorder	0.0034	0.00501	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—GABRA2—conduct disorder	0.00325	0.00478	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—GABRA2—conduct disorder	0.00314	0.00462	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—GABRA2—conduct disorder	0.00314	0.00462	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—CGA—conduct disorder	0.00311	0.00458	CbGpPWpGaD
Bepridil—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00307	0.00452	CbGpPWpGaD
Bepridil—CALM3—IFN-gamma pathway—EP300—conduct disorder	0.00299	0.0044	CbGpPWpGaD
Bepridil—PDE1A—Immune System—POLR3A—conduct disorder	0.00296	0.00436	CbGpPWpGaD
Bepridil—CALM2—IFN-gamma pathway—EP300—conduct disorder	0.00289	0.00426	CbGpPWpGaD
Bepridil—CALM1—IFN-gamma pathway—EP300—conduct disorder	0.00289	0.00426	CbGpPWpGaD
Bepridil—PDE1B—Immune System—POLR3A—conduct disorder	0.00271	0.00398	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—MB21D1—conduct disorder	0.00251	0.00369	CbGpPWpGaD
Bepridil—CALM3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00249	0.00367	CbGpPWpGaD
Bepridil—PDE1A—Immune System—WASF1—conduct disorder	0.00249	0.00367	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—MB21D1—conduct disorder	0.00243	0.00357	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—MB21D1—conduct disorder	0.00243	0.00357	CbGpPWpGaD
Bepridil—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00241	0.00355	CbGpPWpGaD
Bepridil—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00241	0.00355	CbGpPWpGaD
Bepridil—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00237	0.00349	CbGpPWpGaD
Bepridil—PDE1B—Immune System—WASF1—conduct disorder	0.00228	0.00335	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—CGA—conduct disorder	0.00225	0.00331	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—DRD4—conduct disorder	0.0021	0.00309	CbGpPWpGaD
Bepridil—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00204	0.003	CbGpPWpGaD
Bepridil—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00202	0.00298	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CGA—conduct disorder	0.00201	0.00296	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—CGA—conduct disorder	0.00198	0.00291	CbGpPWpGaD
Bepridil—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00197	0.0029	CbGpPWpGaD
Bepridil—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00197	0.0029	CbGpPWpGaD
Bepridil—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00196	0.00288	CbGpPWpGaD
Bepridil—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00196	0.00288	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—DRD4—conduct disorder	0.00192	0.00282	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—DRD4—conduct disorder	0.0019	0.0028	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—COMT—conduct disorder	0.00187	0.00275	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—MAOA—conduct disorder	0.00185	0.00273	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—POLR3A—conduct disorder	0.00184	0.00271	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CGA—conduct disorder	0.00184	0.0027	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—POLR3A—conduct disorder	0.00178	0.00262	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—POLR3A—conduct disorder	0.00178	0.00262	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—DRD4—conduct disorder	0.00174	0.00256	CbGpPWpGaD
Bepridil—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00164	0.00242	CbGpPWpGaD
Bepridil—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00163	0.0024	CbGpPWpGaD
Bepridil—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00162	0.00238	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—WASF1—conduct disorder	0.00161	0.00237	CbGpPWpGaD
Bepridil—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00161	0.00237	CbGpPWpGaD
Bepridil—CACNA1H—Developmental Biology—EP300—conduct disorder	0.00159	0.00234	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—COMT—conduct disorder	0.00157	0.0023	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—COMT—conduct disorder	0.00156	0.0023	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—MAOA—conduct disorder	0.00155	0.00229	CbGpPWpGaD
Bepridil—CALM3—Neuronal System—MAOA—conduct disorder	0.00155	0.00228	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—WASF1—conduct disorder	0.00155	0.00228	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—COMT—conduct disorder	0.00151	0.00222	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—COMT—conduct disorder	0.00151	0.00222	CbGpPWpGaD
Bepridil—CALM1—Neuronal System—MAOA—conduct disorder	0.0015	0.00221	CbGpPWpGaD
Bepridil—CALM2—Neuronal System—MAOA—conduct disorder	0.0015	0.00221	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—WASF1—conduct disorder	0.0015	0.00221	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—WASF1—conduct disorder	0.0015	0.00221	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—WASF1—conduct disorder	0.00147	0.00217	CbGpPWpGaD
Bepridil—CALM3—Immune System—MB21D1—conduct disorder	0.00146	0.00215	CbGpPWpGaD
Bepridil—CALM2—Immune System—MB21D1—conduct disorder	0.00141	0.00208	CbGpPWpGaD
Bepridil—CALM1—Immune System—MB21D1—conduct disorder	0.00141	0.00208	CbGpPWpGaD
Bepridil—PDE1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00137	0.00201	CbGpPWpGaD
Bepridil—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00132	0.00195	CbGpPWpGaD
Bepridil—PDE1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00125	0.00184	CbGpPWpGaD
Bepridil—PDE1A—Signaling by GPCR—HTR2A—conduct disorder	0.00124	0.00183	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CGA—conduct disorder	0.00123	0.00182	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CGA—conduct disorder	0.00119	0.00176	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CGA—conduct disorder	0.00119	0.00176	CbGpPWpGaD
Bepridil—PDE1A—Hemostasis—EP300—conduct disorder	0.00115	0.00169	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—HTR2A—conduct disorder	0.00114	0.00167	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—DRD4—conduct disorder	0.00113	0.00166	CbGpPWpGaD
Bepridil—CACNA1D—Developmental Biology—EP300—conduct disorder	0.0011	0.00161	CbGpPWpGaD
Bepridil—CALM3—Immune System—POLR3A—conduct disorder	0.00107	0.00158	CbGpPWpGaD
Bepridil—PDE1B—Hemostasis—EP300—conduct disorder	0.00105	0.00154	CbGpPWpGaD
Bepridil—CALM1—Immune System—POLR3A—conduct disorder	0.00104	0.00153	CbGpPWpGaD
Bepridil—CALM2—Immune System—POLR3A—conduct disorder	0.00104	0.00153	CbGpPWpGaD
Bepridil—PDE1A—Innate Immune System—EP300—conduct disorder	0.00103	0.00152	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—DRD4—conduct disorder	0.00103	0.00151	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—COMT—conduct disorder	0.00102	0.00149	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—MAOA—conduct disorder	0.00101	0.00148	CbGpPWpGaD
Bepridil—CACNA1C—Developmental Biology—EP300—conduct disorder	0.000962	0.00142	CbGpPWpGaD
Bepridil—PDE1B—Innate Immune System—EP300—conduct disorder	0.000945	0.00139	CbGpPWpGaD
Bepridil—CALM3—Immune System—WASF1—conduct disorder	0.000903	0.00133	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—COMT—conduct disorder	0.000893	0.00131	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—MAOA—conduct disorder	0.000886	0.0013	CbGpPWpGaD
Bepridil—CALM2—Immune System—WASF1—conduct disorder	0.000874	0.00129	CbGpPWpGaD
Bepridil—CALM1—Immune System—WASF1—conduct disorder	0.000874	0.00129	CbGpPWpGaD
Bepridil—CALM3—Metabolism—CGA—conduct disorder	0.000871	0.00128	CbGpPWpGaD
Bepridil—CALM2—Metabolism—CGA—conduct disorder	0.000843	0.00124	CbGpPWpGaD
Bepridil—CALM1—Metabolism—CGA—conduct disorder	0.000843	0.00124	CbGpPWpGaD
Bepridil—CACNA1A—Metabolism—EP300—conduct disorder	0.000801	0.00118	CbGpPWpGaD
Bepridil—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.00079	0.00116	CbGpPWpGaD
Bepridil—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000764	0.00112	CbGpPWpGaD
Bepridil—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000764	0.00112	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HTR2A—conduct disorder	0.000734	0.00108	CbGpPWpGaD
Bepridil—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	0.000734	0.00108	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CGA—conduct disorder	0.000729	0.00107	CbGpPWpGaD
Bepridil—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	0.00071	0.00104	CbGpPWpGaD
Bepridil—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	0.00071	0.00104	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CGA—conduct disorder	0.000705	0.00104	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CGA—conduct disorder	0.000705	0.00104	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—DRD4—conduct disorder	0.000691	0.00102	CbGpPWpGaD
Bepridil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000687	0.00101	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HTR2A—conduct disorder	0.000672	0.000988	CbGpPWpGaD
Bepridil—CACNA2D2—Metabolism—EP300—conduct disorder	0.000671	0.000988	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—DRD4—conduct disorder	0.000668	0.000983	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—DRD4—conduct disorder	0.000668	0.000983	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—CGA—conduct disorder	0.00066	0.000972	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—CGA—conduct disorder	0.000622	0.000916	CbGpPWpGaD
Bepridil—CALM3—Signaling by Wnt—EP300—conduct disorder	0.000605	0.00089	CbGpPWpGaD
Bepridil—PDE1A—Immune System—EP300—conduct disorder	0.000602	0.000885	CbGpPWpGaD
Bepridil—CALM2—Signaling by Wnt—EP300—conduct disorder	0.000585	0.000861	CbGpPWpGaD
Bepridil—CALM1—Signaling by Wnt—EP300—conduct disorder	0.000585	0.000861	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—WASF1—conduct disorder	0.000584	0.000859	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—WASF1—conduct disorder	0.000565	0.000831	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—WASF1—conduct disorder	0.000565	0.000831	CbGpPWpGaD
Bepridil—PDE1A—Disease—EP300—conduct disorder	0.000555	0.000817	CbGpPWpGaD
Bepridil—PDE1B—Immune System—EP300—conduct disorder	0.00055	0.00081	CbGpPWpGaD
Bepridil—PDE1B—Disease—EP300—conduct disorder	0.000508	0.000748	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HTR2A—conduct disorder	0.000451	0.000663	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HTR2A—conduct disorder	0.000436	0.000642	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HTR2A—conduct disorder	0.000436	0.000642	CbGpPWpGaD
Bepridil—CACNA1D—Metabolism—EP300—conduct disorder	0.000436	0.000641	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—EP300—conduct disorder	0.000416	0.000612	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—DRD4—conduct disorder	0.000408	0.000601	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—EP300—conduct disorder	0.000402	0.000592	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—EP300—conduct disorder	0.000402	0.000592	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—DRD4—conduct disorder	0.000395	0.000581	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—DRD4—conduct disorder	0.000395	0.000581	CbGpPWpGaD
Bepridil—CALM3—Metabolism—COMT—conduct disorder	0.000393	0.000579	CbGpPWpGaD
Bepridil—CALM3—Metabolism—MAOA—conduct disorder	0.000391	0.000575	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EP300—conduct disorder	0.000389	0.000572	CbGpPWpGaD
Bepridil—CACNA1C—Metabolism—EP300—conduct disorder	0.000383	0.000563	CbGpPWpGaD
Bepridil—CALM2—Metabolism—COMT—conduct disorder	0.000381	0.00056	CbGpPWpGaD
Bepridil—CALM1—Metabolism—COMT—conduct disorder	0.000381	0.00056	CbGpPWpGaD
Bepridil—CALM2—Metabolism—MAOA—conduct disorder	0.000378	0.000556	CbGpPWpGaD
Bepridil—CALM1—Metabolism—MAOA—conduct disorder	0.000378	0.000556	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EP300—conduct disorder	0.000375	0.000551	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EP300—conduct disorder	0.000362	0.000533	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EP300—conduct disorder	0.000362	0.000533	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EP300—conduct disorder	0.000356	0.000524	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—COMT—conduct disorder	0.000298	0.000439	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—MAOA—conduct disorder	0.000296	0.000436	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—COMT—conduct disorder	0.000281	0.000413	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—MAOA—conduct disorder	0.000279	0.000411	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HTR2A—conduct disorder	0.000266	0.000392	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HTR2A—conduct disorder	0.000258	0.000379	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HTR2A—conduct disorder	0.000258	0.000379	CbGpPWpGaD
Bepridil—CALM3—Immune System—EP300—conduct disorder	0.000218	0.000321	CbGpPWpGaD
Bepridil—CALM1—Immune System—EP300—conduct disorder	0.000211	0.000311	CbGpPWpGaD
Bepridil—CALM2—Immune System—EP300—conduct disorder	0.000211	0.000311	CbGpPWpGaD
Bepridil—CALM3—Disease—EP300—conduct disorder	0.000201	0.000296	CbGpPWpGaD
Bepridil—CALM2—Disease—EP300—conduct disorder	0.000195	0.000287	CbGpPWpGaD
Bepridil—CALM1—Disease—EP300—conduct disorder	0.000195	0.000287	CbGpPWpGaD
Bepridil—CALM3—Metabolism—EP300—conduct disorder	0.000169	0.000248	CbGpPWpGaD
Bepridil—CALM1—Metabolism—EP300—conduct disorder	0.000163	0.00024	CbGpPWpGaD
Bepridil—CALM2—Metabolism—EP300—conduct disorder	0.000163	0.00024	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EP300—conduct disorder	0.000141	0.000208	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EP300—conduct disorder	0.000136	0.000201	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EP300—conduct disorder	0.000136	0.000201	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—EP300—conduct disorder	0.000128	0.000188	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—EP300—conduct disorder	0.00012	0.000177	CbGpPWpGaD
